πŸ‡ΊπŸ‡Έ FDA
Patent

US 12258341

IRAK degraders and uses thereof

granted A61KA61K45/06A61P

Quick answer

US patent 12258341 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kymera Therapeutics, Inc.
Grant date
Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K45/06, A61P, A61P25/00, A61P29/00